1. Home
  2. OLMA vs TRVG Comparison

OLMA vs TRVG Comparison

Compare OLMA & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLMA
  • TRVG
  • Stock Information
  • Founded
  • OLMA 2006
  • TRVG 2005
  • Country
  • OLMA United States
  • TRVG Germany
  • Employees
  • OLMA N/A
  • TRVG N/A
  • Industry
  • OLMA Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • OLMA Health Care
  • TRVG Technology
  • Exchange
  • OLMA Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • OLMA 299.7M
  • TRVG 306.5M
  • IPO Year
  • OLMA 2020
  • TRVG N/A
  • Fundamental
  • Price
  • OLMA $4.20
  • TRVG $3.88
  • Analyst Decision
  • OLMA Strong Buy
  • TRVG Buy
  • Analyst Count
  • OLMA 4
  • TRVG 4
  • Target Price
  • OLMA $24.50
  • TRVG $4.88
  • AVG Volume (30 Days)
  • OLMA 868.7K
  • TRVG 67.1K
  • Earning Date
  • OLMA 08-05-2025
  • TRVG 07-29-2025
  • Dividend Yield
  • OLMA N/A
  • TRVG N/A
  • EPS Growth
  • OLMA N/A
  • TRVG N/A
  • EPS
  • OLMA N/A
  • TRVG N/A
  • Revenue
  • OLMA N/A
  • TRVG $522,618,892.00
  • Revenue This Year
  • OLMA N/A
  • TRVG $17.11
  • Revenue Next Year
  • OLMA N/A
  • TRVG $10.28
  • P/E Ratio
  • OLMA N/A
  • TRVG N/A
  • Revenue Growth
  • OLMA N/A
  • TRVG 1.70
  • 52 Week Low
  • OLMA $2.86
  • TRVG $1.60
  • 52 Week High
  • OLMA $16.62
  • TRVG $5.83
  • Technical
  • Relative Strength Index (RSI)
  • OLMA 43.60
  • TRVG 40.11
  • Support Level
  • OLMA $3.90
  • TRVG $3.88
  • Resistance Level
  • OLMA $4.29
  • TRVG $4.09
  • Average True Range (ATR)
  • OLMA 0.36
  • TRVG 0.19
  • MACD
  • OLMA -0.03
  • TRVG -0.03
  • Stochastic Oscillator
  • OLMA 19.18
  • TRVG 17.39

About OLMA Olema Pharmaceuticals Inc.

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

Share on Social Networks: